Matches in Wikidata for { <http://www.wikidata.org/entity/Q104676368> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q104676368 description "clinical trial" @default.
- Q104676368 description "ensayo clínico" @default.
- Q104676368 description "ensayu clínicu" @default.
- Q104676368 description "klinisch onderzoek" @default.
- Q104676368 description "клінічне випробування" @default.
- Q104676368 description "临床试验" @default.
- Q104676368 name "Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus" @default.
- Q104676368 name "Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus" @default.
- Q104676368 type Item @default.
- Q104676368 label "Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus" @default.
- Q104676368 label "Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus" @default.
- Q104676368 prefLabel "Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus" @default.
- Q104676368 prefLabel "Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus" @default.
- Q104676368 P1132 Q104676368-8D77C0D3-44F6-42BD-ABA5-900B5749188E @default.
- Q104676368 P1476 Q104676368-001A1269-3578-4FAB-8F07-0140B0D0A717 @default.
- Q104676368 P2899 Q104676368-6D28CC61-E2EE-4EFB-BC52-DF9AEAAAD4A8 @default.
- Q104676368 P3098 Q104676368-50DC19FF-C497-4071-A4AC-AE33253D8F43 @default.
- Q104676368 P31 Q104676368-9855EBEC-4488-425E-B728-A3A605687045 @default.
- Q104676368 P4135 Q104676368-7E462BF0-A5F9-4BFD-B60F-CB568860530C @default.
- Q104676368 P580 Q104676368-2AFC4710-ECD1-4446-997E-DB81AA0A19A4 @default.
- Q104676368 P582 Q104676368-DA789589-3767-48A4-A36D-7B67AE4841D5 @default.
- Q104676368 P6099 Q104676368-44685514-D8B4-463E-96F5-E62F01071A86 @default.
- Q104676368 P8005 Q104676368-EB02E9BB-080B-445A-9774-3CEFEB18AED3 @default.
- Q104676368 P8363 Q104676368-2AC0EF30-A5CD-4CF2-9218-FE6529D3E1D1 @default.
- Q104676368 P1132 "+320" @default.
- Q104676368 P1476 "A Phase 2b Dose Ranging Study to Evaluate the Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus With Inadequate Response to Standard of Care Therapy" @default.
- Q104676368 P2899 "+18" @default.
- Q104676368 P3098 "NCT04680637" @default.
- Q104676368 P31 Q30612 @default.
- Q104676368 P4135 "+75" @default.
- Q104676368 P580 "2021-05-25T00:00:00Z" @default.
- Q104676368 P582 "2024-06-19T00:00:00Z" @default.
- Q104676368 P6099 Q42824440 @default.
- Q104676368 P8005 Q76649614 @default.
- Q104676368 P8363 Q78089383 @default.